Impact of Underlying Portal Hypertension on Severity and Course of Acute‐On‐Chronic Liver Failure
Vlad Țâru(Iuliu Hațieganu University of Medicine and Pharmacy), Benedikt Simbrunner(Austrian Academy of Sciences), Nina Dominik(Medical University of Vienna), Michael Trauner(Medical University of Vienna), Mathias Schneeweiss‐Gleixner(Medical University of Vienna), Thomas Reiberger(ERN GUARD-Heart), Benedikt Hofer(Austrian Academy of Sciences), Lorenz Balcar(Medical University of Vienna), Philipp Schwabl(Austrian Academy of Sciences), Mattias Mandorfer(Medical University of Vienna), Georg Kramer(Medical University of Vienna), Bogdan Procopeț(Iuliu Hațieganu University of Medicine and Pharmacy)
Cited by 1
Related Papers
Pathophysiological mechanisms of liver injury in COVID‐19
|Liver International|2020|399
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score
|Journal of Hepatology|2021|309
Inflammasomes in chronic liver disease: Hepatic injury, fibrosis progression and systemic inflammation
|Journal of Hepatology|2024|239
Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality
|Journal of Hepatology|2020|202
Alcohol Abstinence Improves Prognosis Across All Stages of Portal Hypertension in Alcohol-Related Cirrhosis
|Clinical Gastroenterology and Hepatology|2022|130